Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Random physician effect and comparative effectiveness of treatment for ductal carcinoma in situ.

Virnig BA, Tuttle TM.

J Natl Cancer Inst. 2011 Jan 19;103(2):81-2. doi: 10.1093/jnci/djq511. Epub 2011 Jan 3. No abstract available.

PMID:
21200026
2.

Comparative effectiveness of ductal carcinoma in situ management and the roles of margins and surgeons.

Dick AW, Sorbero MS, Ahrendt GM, Hayman JA, Gold HT, Schiffhauer L, Stark A, Griggs JJ.

J Natl Cancer Inst. 2011 Jan 19;103(2):92-104. doi: 10.1093/jnci/djq499. Epub 2011 Jan 3.

3.

Part IV. Surgery for ductal carcinoma in situ.

Holloway C.

Curr Probl Cancer. 2000 May-Jun;24(3):141-62. Review. No abstract available.

PMID:
10919316
4.

The impact of a focally positive resection margin on the local control in patients treated with breast-conserving therapy.

Park S, Park HS, Kim SI, Koo JS, Park BW, Lee KS.

Jpn J Clin Oncol. 2011 May;41(5):600-8. doi: 10.1093/jjco/hyr018. Epub 2011 Feb 24.

PMID:
21355001
5.

Is excision alone adequate treatment for low-risk ductal carcinoma-in-situ of the breast?

Solin LJ.

J Clin Oncol. 2006 Mar 1;24(7):1017-9. Epub 2006 Feb 6. No abstract available.

PMID:
16461780
6.

Ipsilateral breast tumor recurrence after breast-conserving surgery for ductal carcinoma in situ.

Fujita T.

Ann Surg. 2011 Jun;253(6):1233; author reply 1233-4. doi: 10.1097/SLA.0b013e31821c7ac5. No abstract available.

PMID:
21522008
7.

Local recurrence after partial mastectomy: relation to initial surgical margins.

McCahill LE, Single R, Ratliff J, Sheehey-Jones J, Gray A, James T.

Am J Surg. 2011 Mar;201(3):374-8;discussion 378. doi: 10.1016/j.amjsurg.2010.09.024.

PMID:
21367382
8.

Pathobiological considerations relating to the treatment of intraductal carcinoma (ductal carcinoma in situ) of the breast.

Fisher ER.

CA Cancer J Clin. 1997 Jan-Feb;47(1):52-64. Review. Erratum in: CA Cancer J Clin 1997 Mar-Apr;47(2):68.

9.

Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.

EORTC Breast Cancer Cooperative Group; EORTC Radiotherapy Group, Bijker N, Meijnen P, Peterse JL, Bogaerts J, Van Hoorebeeck I, Julien JP, Gennaro M, Rouanet P, Avril A, Fentiman IS, Bartelink H, Rutgers EJ.

J Clin Oncol. 2006 Jul 20;24(21):3381-7. Epub 2006 Jun 26.

PMID:
16801628
10.

Margin status after breast-conserving treatment of breast cancer: how much free margin is enough?

von Smitten K.

J Surg Oncol. 2008 Dec 15;98(8):585-7. doi: 10.1002/jso.21038. Review.

PMID:
19072849
11.

Can some DCIS patients avoid adjuvant therapy? Still unknown.

Schmidt C.

J Natl Cancer Inst. 2011 Apr 6;103(7):530-1. doi: 10.1093/jnci/djr118. Epub 2011 Mar 23. No abstract available.

PMID:
21436062
12.

[Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from national surgical adjuvant breast and bowel project B-17].

Noël G, Proudhom MA, Mazeron JJ.

Cancer Radiother. 1999 Jul-Aug;3(4):342-3. French. No abstract available.

PMID:
10486547
13.

The effect of age in the outcome and treatment of older women with ductal carcinoma in situ.

Ho A, Goenka A, Ishill N, Van Zee K, McLane A, Gonzales AM, Tan L, Cody H, Powell S, McCormick B.

Breast. 2011 Feb;20(1):71-7. doi: 10.1016/j.breast.2010.07.005. Epub 2010 Aug 23.

14.

Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies.

Jenkinson AD, Al-Mufti RA, Mohsen Y, Berry MJ, Wells C, Carpenter R.

Eur J Surg Oncol. 2001 Feb;27(1):21-5.

PMID:
11237487
15.

[Small DCIS: In favour of postoperative radiotherapy].

Cutuli B.

Gynecol Obstet Fertil. 2012 Jun;40(6):384-6. doi: 10.1016/j.gyobfe.2012.04.002. Epub 2012 May 31. French. No abstract available.

PMID:
22658906
16.

[Radiotherapy of breast carcinoma. 2005 version].

Organgruppe "Mammakarzinom" der DEGRO.

Strahlenther Onkol. 2006 Feb;182 Suppl 1:4-28. German. No abstract available.

PMID:
16613299
17.

Evolution of breast-conserving therapy for localized breast cancer.

Schnitt SJ, Harris JR.

J Clin Oncol. 2008 Mar 20;26(9):1395-6. doi: 10.1200/JCO.2007.14.1432. No abstract available.

PMID:
18349387
18.

[Conservative therapy of I and II stage breast cancer--successful alternative to modified radical mastectomy].

Parvanova VM, Pandova VV, Garanina ZM.

Vopr Onkol. 2001;47(1):45-8. Russian.

PMID:
11317534
19.

Prospective study of wide excision alone for ductal carcinoma in situ of the breast.

Lagios MD, Page DL, Silverstein MJ.

J Clin Oncol. 2006 Aug 10;24(23):3809-11; author reply 3811-2. No abstract available.

PMID:
16896011
20.

Supplemental Content

Support Center